KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesDividends payablesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LifeMD (LFMD) Short-term Investments (2019 - 2025)

LifeMD's Short-term Investments history spans 7 years, with the latest figure at $320217.0 for Q4 2025.

  • For Q4 2025, Short-term Investments rose 681.02% year-over-year to $320217.0; the TTM value through Dec 2025 reached $320217.0, up 681.02%, while the annual FY2025 figure was $320217.0, 681.02% up from the prior year.
  • Short-term Investments reached $320217.0 in Q4 2025 per LFMD's latest filing, down from $371000.0 in the prior quarter.
  • In the past five years, Short-term Investments ranged from a high of $1.4 million in Q2 2021 to a low of $41000.0 in Q4 2024.
  • Average Short-term Investments over 5 years is $393421.9, with a median of $248500.0 recorded in 2023.
  • Peak YoY movement for Short-term Investments: tumbled 91.56% in 2024, then surged 681.02% in 2025.
  • A 5-year view of Short-term Investments shows it stood at $204000.0 in 2021, then crashed by 37.75% to $127000.0 in 2022, then skyrocketed by 282.56% to $485850.0 in 2023, then plummeted by 91.56% to $41000.0 in 2024, then soared by 681.02% to $320217.0 in 2025.
  • Per Business Quant, the three most recent readings for LFMD's Short-term Investments are $320217.0 (Q4 2025), $371000.0 (Q3 2025), and $251000.0 (Q2 2025).